体育运动中的血友病：一例病例报告及预防方案
Hemophilia in Sports: A Case Report and Prophylactic Protocol.
作者信息
Maffet Mark, Roton Jimmy
机构信息
Houston Methodist Orthopedics and Sports Medicine, TX.
St John's School, Houston, TX.
出版信息
J Athl Train. 2017 Jan;52(1):65-70. doi: 10.4085/1062-6050-51.11.14. Epub 2016 Nov 18.
OBJECTIVE
To describe a successful prophylactic protocol for managing an athlete with hemophilia playing at a high level of contact sports.
BACKGROUND
Published data show that team physicians are not comfortable either treating athletes with bleeding disorders or allowing them to participate in contact sports. Much of the literature historically has recommended against allowing athletes with bleeding disorders to play sports at all and certainly against playing contact sports. Hemophilia treatment can now include prophylactic injections of recombinant factor VIII to prevent bleeding episodes. Modern treatments hold the promise of allowing athletes with hemophilia to participate in contact sports.
DIFFERENTIAL DIAGNOSIS
Mild, moderate, or severe hemophilia; von Willebrand disease; other factor deficiencies.
TREATMENT
A treatment protocol was developed that included prophylactic factor VIII injections on a regular basis and when the athlete was injured.
UNIQUENESS
This is the first published case report of an athlete with known hemophilia being successfully treated and participating in National Collegiate Athletic Association collegiate basketball for 2 full seasons.
CONCLUSIONS
Sports medicine teams can successfully manage an athlete with hemophilia playing a contact sport.
目的
描述一种成功的预防性方案，用于管理患有血友病且从事高水平接触性运动的运动员。
背景
已发表的数据表明，队医在治疗出血性疾病运动员或允许他们参加接触性运动方面并不自在。历史上的许多文献都建议完全不允许出血性疾病运动员参加运动，当然更反对参加接触性运动。血友病治疗现在可以包括预防性注射重组凝血因子VIII以预防出血发作。现代治疗有望使患有血友病的运动员能够参加接触性运动。
鉴别诊断
轻度、中度或重度血友病；血管性血友病；其他因子缺乏症。
治疗
制定了一种治疗方案，包括定期以及在运动员受伤时预防性注射凝血因子VIII。
独特之处
这是首例已发表的关于已知患有血友病的运动员成功接受治疗并参加美国大学体育协会大学篮球比赛整整两个赛季的病例报告。
结论
运动医学团队可以成功管理患有血友病且从事接触性运动的运动员。
Zotero 插件